Ultraviolet dosage and decontamination efficacy were widely variable across 14 UV devices after testing a dried enveloped ribonucleic acid virus surrogate for SARS-CoV-2.

The dosages and efficacy of 14 ultraviolet (UV) decontamination technologies were measured against a SARS-CoV-2 surrogate virus that was dried onto different materials for laboratory and field testing. A live enveloped, ribonucleic acid (RNA) virus surrogate for SARS-CoV-2 was dried on stainless steel 304 (SS304), Navy Top Coat-painted SS304 (NTC), cardboard, polyurethane, polymethyl methacrylate (PMMA), and acrylonitrile butadiene styrene (ABS) materials at > 8.0 log plaque-forming units (PFU) per test coupon.

In schizophrenia, are lack of capacity and lack of insight more usefully understood as anosognosia?

Objective: To argue that lack of capacity, lack of insight and anosognosia represent different facets of an interconnected, underlying process.

Methods: Electronic and manual literature search.

Results: There is demographic, clinical, neurocognitive and possible neuroanatomical overlap between lack of capacity, lack of insight and anosognosia.

On unearned privilege in clinical practice.

Objective: To explore what it might mean to be a white psychiatrist working in a white culture.

Conclusions: Inequalities and power imbalances are maintained by person-blaming and the invisibility of structural inequality. Opportunities to recognise the effects of being privileged and working within a medical culture that compounds such inequality may be squandered without curiosity and action.

Anosognosia and schizophrenia - a reminder.

Objective: To remind the clinical and legal practitioner that anosognosia is a recognised facet of schizophrenia with implications for capacity assessment and for relating effectively with people who experience it.

Conclusions: The term anosognosia emphasises that, in schizophrenia, lack of capacity is the result of a neurological deficit. Under-appreciation of this may place that person at risk of a preventable harm.

On being paternalistic.

Objective: What does 'being paternalistic' mean?

Conclusion: Being paternalistic embodies a complex set of ideas that are currently viewed pejoratively, but which retain at its core, the goal of doing something good.

Coercive care and human rights; a complex juxtaposition - part 2.

Objective: To examine capacity assessment, coercive care and principles by which a seemingly reasonable request for the discontinuation of treatment may be considered.

Conclusions: A clinical and socio-legal case may be made for 'coercive care'.

Coercive care and human rights; a complex juxtaposition - part 1.

Objective: To explore the clinical implications associated with the United Nations Convention on the Rights of Persons with Disabilities (UN-CRPD), and coercive practice.

Conclusions: Both human rights and clinical perspectives are necessary in the management of the mentally ill.

Clinically, what ought we to believe?

Objective:: To question the status of the randomised controlled trial (RCT) in the hierarchy of evidence.

Conclusions:: The RCT provides important and clinically relevant information, particularly in psychopharmacology. However, and as with other methodologies, RCTs too are flawed and automatic abdication to their conclusions, especially in complex social interventions, is unwise.

Attitudes Toward Electroconvulsive Therapy Compared With Cardioversion.

Aim: The aim of this study was to examine the patient preference for electroconvulsive therapy and for cardioversion. The latter was regarded as a proxy control group because each patient had also experienced a life-threatening illness for which there were both pharmacological and electrical options available.

Methods: A retrospective, semistructured, telephone survey of patients from a public, rural Australian hospital who had received either electroconvulsive therapy or cardioversion was undertaken.

Does electrode placement predict time to rehospitalization?

We sought to determine whether electrode placement influenced time to rehospitalization. A retrospective review of an elderly, depressed population that had received bitemporal, bifrontal or 6 x RUL ECT was examined to determine time to rehospitalization. Bitemporal ECT was associated with a statistically significant reduction in the number of (P = 0.

Bifrontal electroconvulsive therapy in the elderly: a 2-year retrospective.

Objectives: We sought to examine the clinical effect of bifrontal (BF) electroconvulsive therapy (ECT) in depressed patients aged 65 years and older.

Methods: A retrospective chart review of all patients who received BF ECT for a depressive disorder between January 2000 and December 2002 was made.

Results: Fourteen patients, with a mean age of 73.

Right unilateral electroconvulsive therapy at six times seizure threshold.

Objective: To examine the clinical practice of right unilateral electroconvulsive therapy (ECT) administered at six times seizure threshold (6 x RUL ECT).

Method: A retrospective review of all patients who received 6 x RUL ECT between July 2000 and June 2002.

Results: Twenty-one patients across a range of ages and diagnostic groups received D'Elia unilateral ECT at a seizure dosage at or above 388.

Right unilateral ECT at 6x seizure threshold: is it effective in the psychoses?

Objective: To date, right unilateral electroconvulsive therapy administered at 6x seizure threshold (6x RUL-ECT) has been described in relation to unipolar depression alone. For clinicians who have developed an experience and confidence in bilateral ECT, the effectiveness of 6x RUL-ECT in other psychiatric disorders, particularly those who are severely ill, has remained untested and therefore unknown. This article describes the results of 6x RUL-ECT in a select series of patients with a nondepressive psychotic illness.

ECT in the Asia Pacific region: what do we know?

Objective: To review and describe the practice of ECT in the Asia Pacific region in the year 2000.

Method: A survey of 34 defined countries within the Asia Pacific region was made prior to the 1st Asia Pacific ECT Conference held in Melbourne, Australia, 2001.

Results: Contact addresses for 23 of 34 countries (70%) were found with responses from 12 different countries (35%).

ECT use delayed in the presence of comorbid mental retardation: a review of clinical and ethical issues.

The objective is to develop a clinically and ethically supportive literature for the use of electroconvulsive therapy (ECT) in patients with mental retardation who are concurrently experiencing a significant psychiatric illness. A review of both the clinical and ethical literature using traditional, manual library methods and the Medline and Psychlit databases was undertaken. In addition, a record of all patients who had undergone ECT at our facility between 1995 and 2000 was examined for patients with comorbid mental retardation.

Australian and US responses to electroconvulsive therapy dosage selection.

Objective: The practice of electroconvulsive therapy (ECT) varies considerably across sites with a lack of certainty as to what constitutes seizure adequacy. The aim of this study was to trial a method to explore decision making and to describe any differences between Australian and US practitioners.

Method: Two hundred and thirty-six consultant psychiatrists from Australia and US were asked what dosage of electrical energy they would prescribe after reading a standardized clinical vignette in which an unremarked upon change in seizure tracings followed the first two treatments.